Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-19-020706)

Filing Details

Accession Number:: 0001213900-19-020706
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-10-21 16:07:46
Reporting Period:: 2019-10-18

Accepted Time:: 2019-10-21 16:07:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1553643	Relmada Therapeutics Inc.	RLMD	Pharmaceutical Preparations (2834)	455401931

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1658544	Edward Paul Kelly	C/O Relmada Therapeutics, Inc. 880 Third Avenue, 12Th Floor New York, NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-10-18	1,000	$18.99	123,121	No	4	P	Direct
Common Stock	Acquisiton	2019-10-18	100	$19.04	123,221	No	4	P	Direct
Common Stock	Acquisiton	2019-10-18	400	$19.07	123,621	No	4	P	Direct
Common Stock	Acquisiton	2019-10-18	100	$19.08	123,721	No	4	P	Direct
Common Stock	Acquisiton	2019-10-18	200	$19.10	123,921	No	4	P	Direct
Common Stock	Acquisiton	2019-10-18	100	$19.15	124,021	No	4	P	Direct
Common Stock	Acquisiton	2019-10-18	3,100	$19.20	127,121	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct